UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) Securities registered pursuant to Section 12(g) of the Act: None ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39513 Outset Medical, Inc. (Exact name of Registrant as specified in ...

| --- | --- | --- ...

Outset Medical, Inc. (NASDAQ:OM) Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Jim Mazzola – Vice President-Investor Relations Leslie Trigg – Chair and Chief Executive Officer Nabeel Ahmed – Chief Financial Officer Conference Call Participants Travis Steed – BofA Securities Joshua Jennings – Cowen Phil Coover – Goldman Sachs Rick Wise – Stifel Suraj Kalia – Oppenheimer Drew Ranieri – Morgan Stanley Operator Good day and thank you for standing by. Welcome to Outset Medical ...

| --- | --- | --- | |-------|-------|-------| | | | | | | | | 2 Forward-looking statements and non-GAAP information This presentation and the accompanying oral statements contain forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expect," "plan," anticipate," "believe," "estimate ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdi ...

Outset Medical, Inc. (NASDAQ:OM) Q2 2022 Earnings Conference Call August 1, 2022 5:00 PM ET Company Participants Jim Mazzola - Vice President Investor Relations Leslie Trigg - Chair & Chief Executive Officer Nabeel Ahmed - Chief Financial Officers Conference Call Participants Travis Steed - Bank of America Josh Jennings - Cowen Suraj Kalia - Oppenheimer Rick Wise - Stifel Phil Coover - Goldman Sachs Drew Ranieri - Morgan Stanley Josh Jennings - Cowen Operator Greetings, and welcome to Outset Medical Q2 2022 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdiction ...

| --- | --- | --- | |-------|-----------------------------------------------------|-------| | | | | | | | | | | | | | | | | | | Outset Medical Investor Presentation May 2022 | | 2 Forward-looking statements and non-GAAP information This presentation and the accompanying oral statements contain forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact are forward-looking statements. In some cases, you can identify forward-looking sta ...

Outset Medical, Inc. (NASDAQ:OM) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Participants Leslie Trigg – Chair and Chief Executive Officer Jim Mazzola – Head of Investor Relations Nabeel Ahmed – Chief Financial Officers Conference Call Participants Philip Coover – Goldman Sachs Rick Wise – Stifle Travis Steed – Bank of America Suraj Kalia – Oppenheimer Josh Jennings – Cowen Danielle Antalffy – SVB Securities Drew Ranieri – Morgan Stanley Operator Good day and thank you for standing by. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39513 Outset Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 20-0514392 (State or other jurisdictio ...